Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Tratamiento de la estenosis mamaria mediante un dispositivo de coagulación con plasma argón en vacas


Oferta Tecnológica
Una empresa turca fue fundada en 2017 para investigar y desarrollar dispositivos veterinarios. La estenosis mamaria es un problema serio en ganadería que causa importantes pérdidas económicas. El dispositivo veterinario de coagulación con plasma argón (VAPCD) ha sido desarrollado y utilizado en animales vivos para el tratamiento de la estenosis mamaria, y se encuentra en el nivel TRL6, es decir, todavía hay que realizar las pruebas de campo. La tasa actual de éxito es superior al 80%. El dispositivo ha sido diseñado realizando una serie de modificaciones en el dispositivo de coagulación con plasma argón empleado con diferentes fines en medicina humana. La empresa busca socios con el fin de ultimar las características técnicas y aspecto estético conforme a los requisitos del mercado y preparar el dispositivo para la producción en serie, así como socios especializados en marketing. La cooperación se establecerá en el marco de un acuerdo de licencia o fabricación.


Treatment of Teat Stenosis with Veterinary Argon Plasma Coagulation Device in Cows
The Company established in 2017 in Turkey to do research and development for veterinary devices: Teat stenosis is a serious problem in stockbreeding causing an important amount of economic loss. The Veterinary Argon Plasma Coagulation Device(VAPCD) has been developed and used on live animals for the treatment of teat stenosis. The device is at TRL6 level which means that field tests are under go. Current success rate in live animals is over 80% .
Congestions affecting the exit of milk from the teat in cows are caused by congenital or acquired disorders. Such disorders in the teat are usually being treated by surgical intervention. However, in both closed and open operations, the main problem is the formation of hemorrhages during and after the operation and accordingly, the formation of fierce adhesions during healing. Again, during the operations, most of the tissues that were cut are tumoral structures and the related processes are frequently encountered because of the increased aggravation of the stenosis due to the fact that these structures cause faster growth. As an alternative to operative methods, there are also studies on the use of various enzymes in teat stenosis. However, it is reported that success is generally limited in such applications.
With the project named "Veterinary Argon Plasma Coagulation Device (2170002)" which was supported by TÜBITAK-TEYDEP within the scope of 1512 programs, Veterinary Argon Plasma Coagulation Device has been developed and has been used on live animals for the treatment of teat stenosis. Yearly 3% - 10% of cows suffers from teat problem. Animals in which the disease was formed are usually removed from the breeding. This situation causes great damage to the livestock economy. (Since the success rate of existing conventional methods is less than 1%, cows affected by this disease are removed from the farm and sent to the slaughterhouse. In this respect, the damage caused is very large by cutting the cows alone. In addition, if these animals were kept in breeding, milk production could continue for years, and calves could be born every year and milk and new calves could be obtained from these calves. The damage is bigger and more serious within this respect)
Argon plasma coagulation technique has achieved a success rate of up to 80% in the treatment of teat stenosis in cows.
Veterinary Argon Plasma Coagulation Device has been designed by making some modifications in argon plasma coagulation device, which is used for different purpose in human medicine. Making serious changes on especially its probes has also made this device, which has been successfully used in human medicine, available in animal health. The other specifications of the Device is a portable mobile tool. In this regard, a new approach to animal health has been introduced by treating the teat stenosis with a portable device which can be taken to animals in barns or farms. In this way, a new device and treatment option has been developed in the field of veterinary medicine in both local and global markets.

Advantages and Innovations:
Veterinary Argon Plasma Coagulation Device was developed based on argon plasma coagulation technique. The company presents Veterinary Argon Plasma Coagulation Device to be produced in European conditions by making some modifications instead of the existing argon plasma coagulation device used in humans, which is expensive. Veterinary Argon Plasma Coagulation Device forms coagulation in the tissue by providing contactless arc formation on living tissue.By the applied electric current, argon gas is converted into plasma and coagulation is formed in the tissue. In this way, stopping bleeding in the tissues, the destruction of the tissues is ensured.Device has a probe diameter of 2 millimeters due to the fact that the cow´s teat is an outer-body part that can be touched by the hand, as it does not require equipment such as camera cutting, cautery, liquid and air supply apparatus.Since current devices used in the prior technique are for human use and the probe part, which is in contact, contains endoscopic features (because of the camera, cutting, cautery, liquid and air handling equipment), its diameter is more than 2 cm.In addition, there is a protective sheath made of stainless steel in order to allow the probe to pass through the teat canal on the 2 mm probe of the Veterinary Argon Plasma Coagulation Device.In this way, an advantageous device has been developed for the treatment of teat stenosis in cows without doubt of its alternative treatment efficacy to conventional treatment methods.There is no information about the use of argon plasma coagulation technique in the veterinary field. At this point, a research has been made in search engines such as Google Academic, Web of Science, PubMed, Scopus. Also, a similar device could not be found in different patent search modules. When the same questioning is done on the basis of veterinarians in the market, it is determined that veterinarians tried to solve the problems related to teat stenosis by using conventional met
Stage of Development:
Field tested/evaluated
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
PCT application is done

Partner sought

Type and Role of Partner Sought:
Company is looking for a partner who would like to cooperate
- to finalize technical features and cosmetic appearance according to market requirements
- to make it ready for mass production
- A partner with marketing ability, preferably a company which is already in the market

License Agreements and/or manufacturing agreements are welcomed.


Type and Size of Client:
Already Engaged in Trans-National Cooperation:
Languages Spoken:


Technology Keywords:
07001002 Ganadería / labranza
07001009 Medicina veterinaria